Literature DB >> 19818763

Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.

Youn Soo Lee1, Seon-Ah Ha, Hae Joo Kim, Seung Min Shin, Hyun Kee Kim, Sanghee Kim, Chang Suk Kang, Kyo Young Lee, Oak Kee Hong, Seung-Hwan Lee, Hyuk-Sang Kwon, Bong-Yun Cha, Jin Woo Kim.   

Abstract

The proliferative capacity of tumor cells is a characteristic feature in the whole growing tumors. Many pathologists and clinicians have used the estimation of cell proliferation for prognostic information. Minichromosome maintenance protein 3 (MCM3) is known to have a role on the initiation and regulation of DNA replication during cell cycle. The aim of this study was to evaluate the potential applicability of one of the MCM proteins, MCM3, as a proliferation marker in papillary thyroid carcinoma (PTC) with correlation to clinicopathological parameters. We performed the immunohistochemical analysis for MCM3 and Ki-67 in 60 cases of PTC and Western blot analysis for MCM3 expression in 6 PTCs and normal thyroid tissues. The comparison of MCM3 labeling index (LI) to tumor size (P=0.031) and extrathyroidal extension (P=0.037) was statistically significant while that of Ki-67 LI to them was not. Moreover, a significant association was not observed between MCM3 and Ki-67, but the MCM3 LI was considerably higher. Western blot analyses revealed that the MCM3 protein expression levels were overexpressed in all PTCs. On the contrary, the levels of MCM3 were very low or absent in all normal thyroid tissues. Our results indicate that MCM3 may be a more reliable proliferation marker than Ki-67 in accessing the growth of tumor and evaluating tumor aggressiveness of PTC. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818763     DOI: 10.1016/j.yexmp.2009.09.015

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  15 in total

1.  Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.

Authors:  Yue Zhao; Yimin Wang; Fudi Zhu; Jiayu Zhang; Xiao Ma; Dongwei Zhang
Journal:  Clin Exp Med       Date:  2020-01-24       Impact factor: 3.984

2.  Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.

Authors:  Yusuf Ziya Igci; Ahmet Arslan; Ersin Akarsu; Suna Erkilic; Mehri Igci; Serdar Oztuzcu; Beyhan Cengiz; Bulent Gogebakan; Ecir Ali Cakmak; A Tuncay Demiryurek
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

3.  MCM3 protein expression in follicular and classical variants of papillary thyroid carcinoma.

Authors:  Yusuf Ziya Igci; Suna Erkilic; Mehri Igci; Ahmet Arslan
Journal:  Pathol Oncol Res       Date:  2013-07-03       Impact factor: 3.201

4.  MCM3AP, a novel HBV integration site in hepatocellular carcinoma and its implication in hepatocarcinogenesis.

Authors:  Jing Wang; Jusheng Lin; Ying Chang; Peiyuan Li; Yuzhen Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

5.  MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Authors:  Eun Young Kang; Joshua Millstein; Gordana Popovic; Nicola S Meagher; Adelyn Bolithon; Aline Talhouk; Derek S Chiu; Michael S Anglesio; Betty Leung; Katrina Tang; Neil Lambie; Marina Pavanello; Annalyn Da-Anoy; Diether Lambrechts; Liselore Loverix; Siel Olbrecht; Christiani Bisinotto; Jesus Garcia-Donas; Sergio Ruiz-Llorente; Monica Yagüe-Fernandez; Robert P Edwards; Esther Elishaev; Alexander Olawaiye; Sarah Taylor; Beyhan Ataseven; Andreas du Bois; Philipp Harter; Jenny Lester; Claus K Høgdall; Sebastian M Armasu; Yajue Huang; Robert A Vierkant; Chen Wang; Stacey J Winham; Sabine Heublein; Felix K F Kommoss; Daniel W Cramer; Naoko Sasamoto; Lilian van-Wagensveld; Maria Lycke; Constantina Mateoiu; Janine Joseph; Malcolm C Pike; Kunle Odunsi; Chiu-Chen Tseng; Celeste L Pearce; Sanela Bilic; Thomas P Conrads; Arndt Hartmann; Alexander Hein; Michael E Jones; Yee Leung; Matthias W Beckmann; Matthias Ruebner; Minouk J Schoemaker; Kathryn L Terry; Mona A El-Bahrawy; Penny Coulson; John L Etter; Katherine LaVigne-Mager; Juergen Andress; Marcel Grube; Anna Fischer; Nina Neudeck; Greg Robertson; Rhonda Farrell; Ellen Barlow; Carmel Quinn; Anusha Hettiaratchi; Yovanni Casablanca; Ramona Erber; Colin J R Stewart; Adeline Tan; Yu Yu; Jessica Boros; Alison H Brand; Paul R Harnett; Catherine J Kennedy; Nikilyn Nevins; Terry Morgan; Peter A Fasching; Ignace Vergote; Anthony J Swerdlow; Francisco J Candido Dos Reis; G Larry Maxwell; Susan L Neuhausen; Arantzazu Barquin-Garcia; Francesmary Modugno; Kirsten B Moysich; Philip J Crowe; Akira Hirasawa; Florian Heitz; Beth Y Karlan; Ellen L Goode; Peter Sinn; Hugo M Horlings; Estrid Høgdall; Karin Sundfeldt; Stefan Kommoss; Annette Staebler; Anna H Wu; Paul A Cohen; Anna DeFazio; Cheng-Han Lee; Helen Steed; Nhu D Le; Simon A Gayther; Kate Lawrenson; Paul D P Pharoah; Gottfried Konecny; Linda S Cook; Susan J Ramus; Linda E Kelemen; Martin Köbel
Journal:  Virchows Arch       Date:  2021-11-15       Impact factor: 4.535

6.  The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration.

Authors:  Manuela Torres Andion Vidal; Sílvia Vanessa Lourenço; Fernando Augusto Soares; Clarissa Araújo Gurgel; Eduardo J B Studart; Ludmila de Faro Valverde; Iguaracyra Barreto de Oliveira Araújo; Eduardo Antônio Gonçalves Ramos; Flávia Caló de Aquino Xavier; Jean Nunes Dos Santos
Journal:  Tumour Biol       Date:  2016-01-21

7.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

8.  High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.

Authors:  Björn Nodin; Marie Fridberg; Liv Jonsson; Julia Bergman; Mathias Uhlén; Karin Jirström
Journal:  Diagn Pathol       Date:  2012-07-17       Impact factor: 2.644

Review 9.  MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity.

Authors:  Mitali Das; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Mol Biol Int       Date:  2014-10-19

10.  MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma.

Authors:  Zohreh Jaafari-Ashkavandi; Fatemeh Mehranmehr; Elham Roosta
Journal:  J Oral Biol Craniofac Res       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.